• Profile
Close

The NACSTOP trial: A multi-center, cluster-controlled trial of early cessation of acetylcysteine in acetaminophen overdose

Hepatology Aug 23, 2018

Wong A, et al. - Given that historically, acetylcysteine has been delivered at a fixed dose and duration of 300 mg/kg over 20 hours to nearly every patient deemed to be at any risk for hepatotoxicity following acetaminophen overdose, researchers examined a 12-hour treatment regimen for selected low-risk patients in this multicenter, open-label, cluster-controlled trial at six metropolitan Emergency Departments. The findings from the present study suggested that discontinuing acetylcysteine based on laboratory testing after 12 hours of treatment was feasible and likely safe in selected patients at very low risk of liver injury from acetaminophen overdose.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay